,Set,NGenes,Direction,PValue,FDR
1,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Down,0.00123089407543949,0.500182336025992
2,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Up,0.00126071820167501,0.500182336025992
3,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,17,Up,0.00216146416337091,0.500182336025992
4,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,17,Down,0.00243926634137943,0.500182336025992
5,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,21,Up,0.00348912628358656,0.500182336025992
6,WP_IDO_METABOLIC_PATHWAY,8,Down,0.00396409433625512,0.500182336025992
7,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Up,0.00425946028245978,0.500182336025992
8,WP_OXIDATIVE_PHOSPHORYLATION,50,Up,0.00597165836217684,0.540256328802452
9,WP_MALE_INFERTILITY,68,Up,0.0067498055550936,0.540256328802452
10,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,4,Down,0.00822659912125481,0.540256328802452
11,WP_IRON_METABOLISM_DISORDERS,10,Up,0.0086572759629577,0.540256328802452
12,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,15,Down,0.00867142976389491,0.540256328802452
13,WP_MEVALONATE_PATHWAY,7,Down,0.00910969866339609,0.540256328802452
14,WP_RETINOL_METABOLISM,6,Down,0.0102656738654855,0.540256328802452
15,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Up,0.0103100586977052,0.540256328802452
16,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Up,0.010515938273527,0.540256328802452
17,WP_NUCLEOTIDE_GPCRS,5,Down,0.0114844342143705,0.555306172012502
18,WP_GENES_CONTROLLING_NEPHROGENESIS,13,Up,0.0130760197009191,0.561630092399332
19,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,28,Down,0.0135950357647413,0.561630092399332
20,WP_TP53_NETWORK,16,Up,0.0140864102165651,0.561630092399332
21,WP_IRON_METABOLISM_IN_PLACENTA,8,Up,0.0152053102182219,0.561630092399332
22,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,9,Up,0.0153317048687131,0.561630092399332
23,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Down,0.0159459938397639,0.561630092399332
24,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,7,Down,0.0163979589021703,0.561630092399332
25,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,9,Down,0.017827200152753,0.586158341022518
26,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,70,Down,0.0193835461095888,0.592161886569125
27,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,18,Up,0.0201122399793207,0.592161886569125
28,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Down,0.0201709645060043,0.592161886569125
29,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Up,0.0249050205225845,0.705928512743601
30,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,18,Down,0.0262509325591309,0.719275552120188
31,WP_EFFECTS_OF_MFN2_MUTATION,18,Up,0.0284726303719301,0.722044598876509
32,WP_GDNFRET_SIGNALING_AXIS,4,Up,0.028614648054863,0.722044598876509
33,WP_INFLAMMATORY_RESPONSE_PATHWAY,14,Up,0.0298247317334864,0.722044598876509
34,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,72,Up,0.0298655916810235,0.722044598876509
35,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,26,Up,0.032038653554723,0.752450663485209
36,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,40,Down,0.0341159377735795,0.778980579163398
37,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Down,0.0378870156364956,0.802838565195609
38,WP_ESTROGEN_METABOLISM_WP697,5,Up,0.0389285109494688,0.802838565195609
39,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Down,0.03896495526372,0.802838565195609
40,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,27,Down,0.039484164004971,0.802838565195609
41,WP_BREAST_CANCER_PATHWAY,88,Up,0.0407612741746242,0.802838565195609
42,WP_PANCREATIC_CANCER_SUBTYPES,5,Down,0.041679334266656,0.802838565195609
43,WP_BLOOD_CLOTTING_CASCADE,5,Down,0.0433093971188375,0.802838565195609
44,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,10,Down,0.0442305474734778,0.802838565195609
45,WP_PILOCYTIC_ASTROCYTOMA,6,Down,0.0442846249031431,0.802838565195609
46,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,14,Down,0.045796306418423,0.802838565195609
47,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Up,0.0464401285911342,0.802838565195609
48,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,20,Up,0.0479550563952719,0.802838565195609
49,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Up,0.0500716657963578,0.802838565195609
50,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,7,Up,0.0517932873234708,0.802838565195609
51,WP_DNA_DAMAGE_RESPONSE,59,Up,0.0520835646058976,0.802838565195609
52,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,77,Up,0.0523415655229398,0.802838565195609
53,WP_GPCRS_CLASS_B_SECRETINLIKE,4,Up,0.0542401473164144,0.802838565195609
54,WP_ID_SIGNALING,12,Up,0.054412961023195,0.802838565195609
55,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Up,0.0549818534937597,0.802838565195609
56,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,19,Down,0.0555306060237282,0.802838565195609
57,WP_CELL_DIFFERENTIATION_INDEX,7,Down,0.0561711709435701,0.802838565195609
58,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,28,Down,0.0566479766196415,0.802838565195609
59,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Up,0.0578854240810964,0.806471501604428
60,WP_PROSTAGLANDIN_SIGNALING,22,Down,0.0616021313800482,0.807059176939016
61,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,61,Up,0.0617240091332832,0.807059176939016
62,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Up,0.0633493644356709,0.807059176939016
63,WP_MONOAMINE_GPCRS,3,Down,0.0646954648222279,0.807059176939016
64,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Up,0.0672008531732269,0.807059176939016
65,WP_HUNGER_AND_SATIETY,2,Down,0.0674787778482378,0.807059176939016
66,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,19,Down,0.0677788579887272,0.807059176939016
67,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Down,0.0689296682064942,0.807059176939016
68,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,27,Up,0.0694943369149271,0.807059176939016
69,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Up,0.0701957422971089,0.807059176939016
70,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,21,Up,0.0714288488301379,0.807059176939016
71,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,60,Up,0.0726977991813026,0.807059176939016
72,WP_ARYLAMINE_METABOLISM,1,Up,0.0760846352189639,0.807059176939016
73,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,4,Up,0.0764260634685194,0.807059176939016
74,WP_TAMOXIFEN_METABOLISM,2,Up,0.0766487593861114,0.807059176939016
75,WP_PROTEOGLYCAN_BIOSYNTHESIS,15,Down,0.077717002160855,0.807059176939016
76,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,11,Down,0.0779912443559436,0.807059176939016
77,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,43,Up,0.0825523470365806,0.807059176939016
78,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,10,Up,0.0827337267073865,0.807059176939016
79,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,21,Up,0.0837251462176127,0.807059176939016
80,WP_FERROPTOSIS,50,Up,0.085762321529179,0.807059176939016
81,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,37,Up,0.0887144290130654,0.807059176939016
82,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Down,0.0893050121990053,0.807059176939016
83,WP_NRXN1_DELETION_SYNDROME,2,Up,0.0893178412487331,0.807059176939016
84,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,9,Up,0.090162608912677,0.807059176939016
85,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,13,Down,0.0903274296503192,0.807059176939016
86,WP_ANGIOGENESIS,13,Up,0.0905146565665505,0.807059176939016
87,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,129,Up,0.0911802625064909,0.807059176939016
88,WP_FATTY_ACID_TRANSPORTERS,10,Up,0.0916289146984778,0.807059176939016
89,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,3,Up,0.0916548929563179,0.807059176939016
90,WP_RAS_SIGNALING,116,Up,0.0920116015275488,0.807059176939016
91,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Up,0.0946189228113736,0.807059176939016
92,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,6,Up,0.0949845710161467,0.807059176939016
93,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,4,Up,0.0954078063249156,0.807059176939016
94,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,9,Up,0.0984769039903623,0.807059176939016
95,WP_GABA_RECEPTOR_SIGNALING,9,Up,0.0993122891015691,0.807059176939016
96,WP_CANNABINOID_RECEPTOR_SIGNALING,17,Down,0.0999566400791762,0.807059176939016
97,WP_LIVER_X_RECEPTOR_PATHWAY,5,Up,0.100310621508236,0.807059176939016
98,WP_IL7_SIGNALING,23,Up,0.100624196186021,0.807059176939016
99,WP_SPHINGOLIPID_PATHWAY,20,Down,0.101089701830504,0.807059176939016
100,WP_NEURAL_CREST_DIFFERENTIATION,41,Up,0.101504624778737,0.807059176939016
101,WP_ENERGY_METABOLISM,41,Down,0.10196734168364,0.807059176939016
102,WP_CCL18_SIGNALING,20,Up,0.10218541783417,0.807059176939016
103,WP_OXIDATIVE_DAMAGE_RESPONSE,32,Up,0.102424721746743,0.807059176939016
104,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Up,0.103611379106587,0.807059176939016
105,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,12,Down,0.103880921344371,0.807059176939016
106,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,39,Up,0.10443965581042,0.807059176939016
107,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,46,Down,0.105055148336344,0.807059176939016
108,WP_MITOCHONDRIAL_GENE_EXPRESSION,16,Down,0.109797432030975,0.812761620976753
109,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Up,0.109814681516871,0.812761620976753
110,WP_COMPLEMENT_ACTIVATION,12,Up,0.110366250038303,0.812761620976753
111,WP_FOLATE_METABOLISM,36,Up,0.110469588678143,0.812761620976753
112,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,5,Up,0.111164264809636,0.812761620976753
113,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Down,0.111730003856902,0.812761620976753
114,WP_G13_SIGNALING,29,Down,0.11400806470764,0.82205815078667
115,WP_ATR_SIGNALING,10,Up,0.115042876000157,0.822306470192427
116,WP_ZINC_HOMEOSTASIS,21,Up,0.119177919937492,0.823994974163023
117,WP_CANCER_PATHWAYS,306,Up,0.119982951998091,0.823994974163023
118,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,11,Up,0.120988937583534,0.823994974163023
119,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,10,Up,0.121238116938603,0.823994974163023
120,WP_VITAMIN_A1_AND_A5X_PATHWAYS,3,Up,0.121287018840369,0.823994974163023
121,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,37,Down,0.121936139361084,0.823994974163023
122,WP_SELENIUM_MICRONUTRIENT_NETWORK,49,Up,0.122296091055826,0.823994974163023
123,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,52,Up,0.123403888427574,0.824699156808666
124,WP_OXIDATION_BY_CYTOCHROME_P450,15,Down,0.126208884571311,0.83664276707756
125,WP_ONECARBON_METABOLISM,22,Up,0.12785836382139,0.840796600489463
126,WP_TRIACYLGLYCERIDE_SYNTHESIS,18,Down,0.128894257365322,0.840881583764242
127,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,7,Up,0.134117675163865,0.86754181692425
128,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Up,0.135091669788691,0.86754181692425
129,WP_THIAMINE_METABOLIC_PATHWAYS,9,Up,0.139616067867313,0.877801545807675
130,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,12,Down,0.1401574129526,0.877801545807675
131,WP_THERMOGENESIS,74,Down,0.140284166507863,0.877801545807675
132,WP_TRANSLATION_FACTORS,49,Down,0.140960832173495,0.877801545807675
133,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Down,0.143134261608412,0.884634308587331
134,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Down,0.146569574603806,0.890884837090524
135,WP_ERBB_SIGNALING,68,Up,0.147266091517655,0.890884837090524
136,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,3,Up,0.147527870761018,0.890884837090524
137,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Down,0.148480806181754,0.890884837090524
138,WP_PEPTIDE_GPCRS,15,Up,0.155773288322687,0.917716437251809
139,WP_PROXIMAL_TUBULE_TRANSPORT,25,Down,0.155859413994202,0.917716437251809
140,WP_COPPER_HOMEOSTASIS,39,Up,0.156302069604931,0.917716437251809
141,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,47,Up,0.159882502212346,0.920447735458099
142,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Down,0.16089272553576,0.920447735458099
143,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Up,0.161458198575834,0.920447735458099
144,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,22,Down,0.162323385804981,0.920447735458099
145,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,11,Up,0.162366084721927,0.920447735458099
146,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Down,0.163599253327554,0.921086207090751
147,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,22,Up,0.166704362815397,0.932183579824876
148,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,77,Down,0.167997778571882,0.93290759868234
149,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,31,Up,0.169103688812249,0.93290759868234
150,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,14,Up,0.173040195186851,0.935797353429651
151,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,1,Down,0.173856110203539,0.935797353429651
152,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,15,Down,0.174977004448099,0.935797353429651
153,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Up,0.175390564917317,0.935797353429651
154,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,49,Down,0.176523392529434,0.935797353429651
155,WP_CIRCADIAN_RHYTHM_GENES,121,Up,0.177513543807699,0.935797353429651
156,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Up,0.183803875721238,0.935797353429651
157,WP_NAD_BIOSYNTHETIC_PATHWAYS,20,Down,0.184339124468009,0.935797353429651
158,WP_ETHER_LIPID_BIOSYNTHESIS,16,Down,0.188995297840549,0.935797353429651
159,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Down,0.189114531819108,0.935797353429651
160,WP_IL3_SIGNALING,46,Down,0.191496808828818,0.935797353429651
161,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,5,Down,0.194336355845787,0.935797353429651
162,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,42,Down,0.195273524093983,0.935797353429651
163,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,12,Up,0.195540631774033,0.935797353429651
164,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,13,Up,0.19555834312766,0.935797353429651
165,WP_KCNQ2RELATED_EPILEPSIES,11,Down,0.196668154038282,0.935797353429651
166,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,17,Up,0.197596098417346,0.935797353429651
167,WP_PPARALPHA_PATHWAY,15,Up,0.19798866662741,0.935797353429651
168,WP_DOPAMINE_METABOLISM,7,Up,0.201828312316853,0.935797353429651
169,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Up,0.201828511108737,0.935797353429651
170,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,2,Up,0.201851933405589,0.935797353429651
171,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,37,Up,0.20659189879419,0.935797353429651
172,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,10,Up,0.207164511077989,0.935797353429651
173,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,61,Up,0.207679807487413,0.935797353429651
174,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,12,Up,0.208999290961576,0.935797353429651
175,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,13,Down,0.209083769185779,0.935797353429651
176,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,25,Down,0.211738433527808,0.935797353429651
177,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Up,0.213027286686949,0.935797353429651
178,WP_HIPPOYAP_SIGNALING,16,Up,0.213193166238089,0.935797353429651
179,WP_10Q22Q23_COPY_NUMBER_VARIATION,27,Down,0.214321648206055,0.935797353429651
180,WP_ESTROGEN_SIGNALING,21,Up,0.214416331833363,0.935797353429651
181,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,41,Down,0.215631603451311,0.935797353429651
182,WP_SMALL_LIGAND_GPCRS,7,Up,0.215717686362144,0.935797353429651
183,WP_MITOCHONDRIAL_BETAOXIDATION,8,Down,0.218750148852877,0.935797353429651
184,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Up,0.220759402655194,0.935797353429651
185,WP_ENDOMETRIAL_CANCER,49,Up,0.221749090919033,0.935797353429651
186,WP_IL4_SIGNALING,50,Down,0.222097848832094,0.935797353429651
187,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Up,0.22324327758426,0.935797353429651
188,WP_BURN_WOUND_HEALING,60,Up,0.225604387094153,0.935797353429651
189,WP_GALANIN_RECEPTOR_PATHWAY,10,Up,0.22665618221323,0.935797353429651
190,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,4,Up,0.226762644601572,0.935797353429651
191,WP_ALPHA_6_BETA_4_SIGNALING,26,Down,0.22694207904451,0.935797353429651
192,WP_PAFAH1B1_COPY_NUMBER_VARIATION,9,Down,0.227267677581712,0.935797353429651
193,WP_CHOLESTASIS,9,Up,0.227680120170035,0.935797353429651
194,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,33,Up,0.228936205557087,0.935797353429651
195,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,15,Up,0.22894928390592,0.935797353429651
196,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,56,Up,0.232556406916523,0.935797353429651
197,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,66,Up,0.232986913505847,0.935797353429651
198,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Up,0.233491686668809,0.935797353429651
199,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Down,0.234461052377149,0.935797353429651
200,WP_ALSTROM_SYNDROME,27,Up,0.235184467907086,0.935797353429651
201,WP_LEPTIN_SIGNALING,69,Down,0.235506333106235,0.935797353429651
202,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,87,Up,0.237281983072986,0.935797353429651
203,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Up,0.237929527146985,0.935797353429651
204,WP_FRAGILE_X_SYNDROME,83,Down,0.238472870095339,0.935797353429651
205,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,63,Up,0.238620033813346,0.935797353429651
206,WP_TLR4_SIGNALING_AND_TOLERANCE,26,Down,0.241223922263298,0.935797353429651
207,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,27,Down,0.242083891043701,0.935797353429651
208,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,20,Up,0.242658256353793,0.935797353429651
209,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Down,0.243887538873108,0.935797353429651
210,WP_VITAMIN_B12_METABOLISM,23,Up,0.243898636678363,0.935797353429651
211,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,3,Down,0.244320614464924,0.935797353429651
212,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,21,Down,0.245359543166721,0.935797353429651
213,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Up,0.247664170642287,0.935797353429651
214,WP_NUCLEAR_RECEPTORS_METAPATHWAY,177,Up,0.248408339530482,0.935797353429651
215,WP_4P163_COPY_NUMBER_VARIATION,21,Down,0.253297141026463,0.935797353429651
216,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,10,Up,0.254232846235035,0.935797353429651
217,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,48,Up,0.254594125251041,0.935797353429651
218,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,8,Down,0.255458427639283,0.935797353429651
219,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Up,0.256472450520689,0.935797353429651
220,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Down,0.257214503262107,0.935797353429651
221,WP_MONOAMINE_TRANSPORT,11,Down,0.258581813618436,0.935797353429651
222,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Down,0.260172054851579,0.935797353429651
223,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Down,0.26090462479709,0.935797353429651
224,WP_MINERALOCORTICOID_BIOSYNTHESIS,5,Down,0.261022227141892,0.935797353429651
225,WP_SERINE_METABOLISM,5,Up,0.261424085637861,0.935797353429651
226,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,57,Up,0.261689589363441,0.935797353429651
227,WP_PRION_DISEASE_PATHWAY,28,Up,0.262369559345411,0.935797353429651
228,WP_MELATONIN_METABOLISM_AND_EFFECTS,19,Up,0.263360165462472,0.935797353429651
229,WP_MAPK_SIGNALING,161,Up,0.263549205022021,0.935797353429651
230,WP_APOPTOSIS,72,Up,0.264932318912745,0.935797353429651
231,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,22,Up,0.266086722250684,0.935797353429651
232,WP_EICOSANOID_SYNTHESIS,13,Up,0.267926161672917,0.935797353429651
233,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,16,Up,0.269571347657462,0.935797353429651
234,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,8,Up,0.270178452794528,0.935797353429651
235,WP_P38_MAPK_SIGNALING,31,Down,0.270964935360318,0.935797353429651
236,WP_HEDGEHOG_SIGNALING_WP47,6,Up,0.272778409112153,0.935797353429651
237,WP_SPINAL_CORD_INJURY,66,Up,0.274067221680089,0.935797353429651
238,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,29,Up,0.27523849486897,0.935797353429651
239,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,55,Down,0.275351946580125,0.935797353429651
240,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,28,Down,0.276728411814695,0.935797353429651
241,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Down,0.277962794857469,0.935797353429651
242,WP_ALLOGRAFT_REJECTION,50,Up,0.279029765675838,0.935797353429651
243,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,14,Up,0.279953322701847,0.935797353429651
244,WP_MELANOMA,55,Up,0.281429276084296,0.935797353429651
245,WP_AGERAGE_PATHWAY,54,Up,0.281627980203438,0.935797353429651
246,WP_APOPTOSIS_MODULATION_AND_SIGNALING,77,Up,0.281965817159157,0.935797353429651
247,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,40,Up,0.286163861565548,0.935797353429651
248,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Down,0.287151690927706,0.935797353429651
249,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Down,0.287506402699967,0.935797353429651
250,WP_GLYCOLYSIS_IN_SENESCENCE,11,Down,0.287645008078405,0.935797353429651
251,WP_STEROID_BIOSYNTHESIS,3,Up,0.288532855140861,0.935797353429651
252,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,10,Down,0.289618121451516,0.935797353429651
253,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Down,0.290436209790022,0.935797353429651
254,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Up,0.292037066527222,0.935797353429651
255,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,32,Up,0.292599804851996,0.935797353429651
256,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,48,Down,0.292927285722493,0.935797353429651
257,WP_GLYCOSPHINGOLIPID_METABOLISM,13,Down,0.293892001303777,0.935797353429651
258,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,19,Up,0.294343651053871,0.935797353429651
259,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,10,Up,0.295097329946224,0.935797353429651
260,WP_MESODERMAL_COMMITMENT_PATHWAY,77,Up,0.295994296705242,0.935797353429651
261,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Up,0.298213331717615,0.936236810758022
262,WP_TRYPTOPHAN_METABOLISM,19,Down,0.29841124625134,0.936236810758022
263,WP_SEROTONIN_AND_ANXIETY,7,Up,0.302100033084686,0.94420618705556
264,WP_PARKINSONS_DISEASE_PATHWAY,27,Up,0.308398088377251,0.960239502447349
265,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Down,0.313127480247049,0.961994190096905
266,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,3,Down,0.313263140310786,0.961994190096905
267,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Up,0.313872225637546,0.961994190096905
268,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Up,0.314107292970095,0.961994190096905
269,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,85,Up,0.316858793688643,0.961994190096905
270,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,34,Down,0.318157524919576,0.961994190096905
271,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,93,Up,0.319686249027858,0.961994190096905
272,WP_GLYOXYLATE_METABOLISM,5,Down,0.320081303202748,0.961994190096905
273,WP_TAR_SYNDROME,43,Down,0.320494323309434,0.961994190096905
274,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,22,Up,0.320664730032302,0.961994190096905
275,WP_IL1_SIGNALING,52,Down,0.326670391586231,0.972477673030902
276,WP_POSTCOVID_NEUROINFLAMMATION,11,Down,0.328427577149635,0.972477673030902
277,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,21,Up,0.331307493243242,0.972477673030902
278,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,29,Down,0.333420287570518,0.972477673030902
279,WP_GLUCURONIDATION,7,Up,0.334770886868339,0.972477673030902
280,WP_CHOLESTEROL_METABOLISM,53,Down,0.33490562759981,0.972477673030902
281,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,4,Down,0.335391944301418,0.972477673030902
282,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,30,Up,0.335711955738468,0.972477673030902
283,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,8,Down,0.336177476971858,0.972477673030902
284,WP_NOTCH_SIGNALING_WP268,35,Up,0.337178328551436,0.972477673030902
285,WP_BIOGENIC_AMINE_SYNTHESIS,1,Up,0.340310717893423,0.972477673030902
286,WP_NEUROTRANSMITTER_DISORDERS,1,Up,0.340310717893423,0.972477673030902
287,WP_GABA_METABOLISM_AKA_GHB,4,Down,0.34171207108923,0.972477673030902
288,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,9,Down,0.342952459050465,0.972477673030902
289,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,39,Up,0.343616357669857,0.972477673030902
290,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,50,Up,0.344394664670847,0.972477673030902
291,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,15,Down,0.345978967690193,0.972477673030902
292,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,14,Down,0.346632698791744,0.972477673030902
293,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,4,Down,0.346637418732426,0.972477673030902
294,WP_MICROTUBULE_CYTOSKELETON_REGULATION,35,Down,0.348643553819787,0.974778915781853
295,WP_PREIMPLANTATION_EMBRYO,21,Up,0.351057301805801,0.976862883385822
296,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Up,0.351765709832364,0.976862883385822
297,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,11,Down,0.353328702999838,0.977192455990652
298,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,10,Down,0.355069330585282,0.977192455990652
299,WP_GPCRS_OTHER,12,Down,0.356328722258266,0.977192455990652
300,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,35,Down,0.35663958247834,0.977192455990652
301,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,40,Up,0.358790508522598,0.978651933159394
302,WP_FATTY_ACID_BIOSYNTHESIS,21,Down,0.363176930101773,0.978651933159394
303,WP_FOXA2_PATHWAY,9,Up,0.366220242810216,0.978651933159394
304,WP_LIPID_METABOLISM_PATHWAY,23,Down,0.369713435725143,0.978651933159394
305,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,33,Up,0.371060528515567,0.978651933159394
306,WP_INTERFERON_TYPE_I_SIGNALING,50,Down,0.372986701047673,0.978651933159394
307,WP_13Q1212_COPY_NUMBER_VARIATION,20,Down,0.373690037373259,0.978651933159394
308,WP_ULCERATIVE_COLITIS_SIGNALING,12,Up,0.374422067286911,0.978651933159394
309,WP_AFLATOXIN_B1_METABOLISM,2,Down,0.375212024288611,0.978651933159394
310,WP_AEROBIC_GLYCOLYSIS,10,Up,0.376489556505347,0.978651933159394
311,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,10,Up,0.376489556505347,0.978651933159394
312,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,6,Up,0.376611671006739,0.978651933159394
313,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,4,Down,0.376732645583724,0.978651933159394
314,WP_WNT_SIGNALING_WP428,59,Up,0.379223086531722,0.978651933159394
315,WP_INTEGRATED_CANCER_PATHWAY,41,Up,0.380029749084556,0.978651933159394
316,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,13,Up,0.384017124761066,0.978651933159394
317,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,49,Down,0.384189240615685,0.978651933159394
318,WP_EPO_RECEPTOR_SIGNALING,23,Up,0.386277084853484,0.978651933159394
319,WP_TGFB_SMAD_SIGNALING,7,Down,0.387316227543805,0.978651933159394
320,WP_SYNAPTIC_VESICLE_PATHWAY,22,Up,0.388648342805833,0.978651933159394
321,WP_OXIDATIVE_STRESS_RESPONSE,21,Up,0.388785100208527,0.978651933159394
322,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,7,Up,0.391477109842134,0.978651933159394
323,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,30,Up,0.391729540010584,0.978651933159394
324,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,30,Up,0.394178609017616,0.978651933159394
325,WP_NANOMATERIAL_INDUCED_APOPTOSIS,18,Up,0.394579794666458,0.978651933159394
326,WP_MAPK_CASCADE,30,Up,0.395614524110999,0.978651933159394
327,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,72,Up,0.395779151109341,0.978651933159394
328,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,113,Up,0.398990376794692,0.978651933159394
329,WP_ESTROGEN_RECEPTOR_PATHWAY,8,Up,0.399524757058026,0.978651933159394
330,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,5,Down,0.400952897705781,0.978651933159394
331,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,32,Down,0.404860400426304,0.978651933159394
332,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,15,Up,0.40685848805938,0.978651933159394
333,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,62,Up,0.407043548968196,0.978651933159394
334,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,21,Down,0.407859440171617,0.978651933159394
335,WP_GASTRIC_CANCER_NETWORK_1,18,Down,0.409122029808828,0.978651933159394
336,WP_TRANSSULFURATION_PATHWAY,8,Down,0.410041548490281,0.978651933159394
337,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,15,Down,0.410090280009175,0.978651933159394
338,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,8,Down,0.412579337019335,0.978651933159394
339,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Down,0.413549313550126,0.978651933159394
340,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Up,0.414384584779127,0.978651933159394
341,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,61,Up,0.415126559651429,0.978651933159394
342,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Up,0.417417259985041,0.978651933159394
343,WP_PRIMARY_OVARIAN_INSUFFICIENCY,88,Up,0.421385086734301,0.978651933159394
344,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,18,Up,0.426940640699527,0.978651933159394
345,WP_LEPTININSULIN_SIGNALING_OVERLAP,13,Up,0.426953834210625,0.978651933159394
346,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,90,Up,0.427094332567319,0.978651933159394
347,WP_CARDIAC_HYPERTROPHIC_RESPONSE,44,Up,0.427346831445371,0.978651933159394
348,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Down,0.431127755024019,0.978651933159394
349,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,8,Down,0.434033457541624,0.978651933159394
350,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.436190262433102,0.978651933159394
351,WP_NAD_METABOLISM,12,Down,0.436879300623968,0.978651933159394
352,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,77,Up,0.438756944478084,0.978651933159394
353,WP_BASE_EXCISION_REPAIR,29,Up,0.43980485428498,0.978651933159394
354,WP_SMALL_CELL_LUNG_CANCER,70,Up,0.441181168714701,0.978651933159394
355,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Up,0.441839193646972,0.978651933159394
356,WP_KININKALLIKREIN_PATHWAY,2,Up,0.442257650816276,0.978651933159394
357,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,10,Up,0.442629169407834,0.978651933159394
358,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Down,0.446616876040076,0.978651933159394
359,WP_HYPERTROPHY_MODEL,12,Down,0.446814039797392,0.978651933159394
360,WP_OPIOID_RECEPTOR_PATHWAYS,25,Down,0.447186387682045,0.978651933159394
361,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,7,Down,0.450195708065981,0.978651933159394
362,WP_GLUCOCORTICOID_BIOSYNTHESIS,6,Down,0.452690507529654,0.978651933159394
363,WP_FLUOROACETIC_ACID_TOXICITY,6,Down,0.453401717252825,0.978651933159394
364,WP_NETRINUNC5B_SIGNALING,35,Up,0.454856120231178,0.978651933159394
365,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,19,Up,0.457359807227265,0.978651933159394
366,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,13,Up,0.458223090399397,0.978651933159394
367,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,6,Up,0.459239965156723,0.978651933159394
368,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,7,Down,0.459613081290417,0.978651933159394
369,WP_METABOLIC_EPILEPTIC_DISORDERS,58,Up,0.463627158969738,0.978651933159394
370,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,18,Up,0.466327788307704,0.978651933159394
371,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,13,Up,0.467284992720706,0.978651933159394
372,WP_ACETYLCHOLINE_SYNTHESIS,4,Up,0.467416596222531,0.978651933159394
373,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Up,0.467966788546908,0.978651933159394
374,WP_HEME_BIOSYNTHESIS,8,Up,0.467966788546908,0.978651933159394
375,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,11,Up,0.468209549010718,0.978651933159394
376,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,55,Down,0.468897643076392,0.978651933159394
377,WP_COMPLEMENT_SYSTEM,51,Up,0.46952316111089,0.978651933159394
378,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Up,0.47046948764465,0.978651933159394
379,WP_VITAMIN_D_RECEPTOR_PATHWAY,83,Up,0.472173823565109,0.978651933159394
380,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,30,Up,0.472851538934141,0.978651933159394
381,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,13,Down,0.474065905028536,0.978651933159394
382,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,46,Down,0.474680047040109,0.978651933159394
383,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,15,Up,0.475545932789765,0.978651933159394
384,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Down,0.476432683886509,0.978651933159394
385,WP_EGFEGFR_SIGNALING,138,Up,0.476984708298581,0.978651933159394
386,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,15,Down,0.477237831184519,0.978651933159394
387,WP_PURINERGIC_SIGNALING,15,Down,0.477816207946343,0.978651933159394
388,WP_IL5_SIGNALING,37,Down,0.480527612146183,0.978651933159394
389,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Down,0.482702845067975,0.978651933159394
390,WP_NPHP1_DELETION_SYNDROME,10,Down,0.483572442104063,0.978651933159394
391,WP_CORI_CYCLE,11,Up,0.484217428070091,0.978651933159394
392,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,11,Up,0.485962167407176,0.978651933159394
393,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Up,0.488633123873141,0.978651933159394
394,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,12,Down,0.489858921465027,0.978651933159394
395,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Down,0.494059127008444,0.978651933159394
396,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Up,0.496017338141719,0.978651933159394
397,WP_MEASLES_VIRUS_INFECTION,100,Down,0.496131536294501,0.978651933159394
398,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Up,0.497337903499903,0.978651933159394
399,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,88,Up,0.497405835311405,0.978651933159394
400,WP_TROP2_REGULATORY_SIGNALING,42,Up,0.497645771492144,0.978651933159394
401,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,5,Down,0.501312460178662,0.978651933159394
402,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,29,Up,0.502574336418237,0.978651933159394
403,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,3,Up,0.50321305186497,0.978651933159394
404,WP_OSTEOPONTIN_SIGNALING,11,Down,0.504111855067312,0.978651933159394
405,WP_FOXP3_IN_COVID19,9,Up,0.511155770382126,0.978651933159394
406,WP_PTF1A_RELATED_REGULATORY_PATHWAY,6,Up,0.513130762451367,0.978651933159394
407,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,21,Down,0.513333819939707,0.978651933159394
408,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,11,Down,0.515907446560983,0.978651933159394
409,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,48,Up,0.516256848604664,0.978651933159394
410,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,32,Down,0.517236998709002,0.978651933159394
411,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,5,Up,0.520138865010165,0.978651933159394
412,WP_NRF2_PATHWAY,72,Up,0.52104140482017,0.978651933159394
413,WP_CAMKK2_PATHWAY,29,Up,0.523595015221457,0.978651933159394
414,WP_TCA_CYCLE_IN_SENESCENCE,10,Up,0.523848289056409,0.978651933159394
415,WP_LEUKOTRIENE_METABOLIC_PATHWAY,8,Down,0.525696430014774,0.978651933159394
416,WP_CREATINE_PATHWAY,2,Down,0.527812249881599,0.978651933159394
417,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,20,Down,0.529203846198152,0.978651933159394
418,WP_OREXIN_RECEPTOR_PATHWAY,119,Down,0.530024592322885,0.978651933159394
419,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,45,Down,0.531108649429712,0.978651933159394
420,WP_IL10_ANTIINFLAMMATORY_SIGNALING,10,Down,0.5321605995244,0.978651933159394
421,WP_16P112_PROXIMAL_DELETION_SYNDROME,62,Up,0.533298295594679,0.978651933159394
422,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,28,Up,0.536207718242699,0.978651933159394
423,WP_G_PROTEIN_SIGNALING,62,Up,0.536575829085719,0.978651933159394
424,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,29,Up,0.538054729960152,0.978651933159394
425,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Down,0.538590637777558,0.978651933159394
426,WP_HEDGEHOG_SIGNALING_WP4249,25,Down,0.540914408194004,0.978651933159394
427,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,27,Up,0.541972475283234,0.978651933159394
428,WP_ENDOCHONDRAL_OSSIFICATION,26,Up,0.543552576243128,0.978651933159394
429,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,26,Up,0.543552576243128,0.978651933159394
430,WP_NEOVASCULARIZATION_PROCESSES,22,Up,0.547826027979002,0.978651933159394
431,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,43,Up,0.549735050293663,0.978651933159394
432,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Down,0.550179918284918,0.978651933159394
433,WP_SLEEP_REGULATION,11,Down,0.550216968593625,0.978651933159394
434,WP_PPAR_SIGNALING,39,Up,0.550337165979435,0.978651933159394
435,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,47,Down,0.551319274844265,0.978651933159394
436,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,17,Up,0.551459878196511,0.978651933159394
437,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Down,0.551486039281534,0.978651933159394
438,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,15,Down,0.552600411479948,0.978651933159394
439,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Down,0.553297836417299,0.978651933159394
440,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Up,0.55514163303154,0.978651933159394
441,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,52,Up,0.555522344782442,0.978651933159394
442,WP_HEART_DEVELOPMENT,16,Up,0.555898306968042,0.978651933159394
443,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,12,Down,0.555965420548413,0.978651933159394
444,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,57,Down,0.556690465947141,0.978651933159394
445,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,14,Down,0.559105955923932,0.978651933159394
446,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,136,Up,0.559223804362514,0.978651933159394
447,WP_CYTOSOLIC_DNASENSING_PATHWAY,53,Down,0.560617591877291,0.978651933159394
448,WP_16P112_DISTAL_DELETION_SYNDROME,20,Up,0.560754180226497,0.978651933159394
449,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Down,0.564180743247824,0.978651933159394
450,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Up,0.564342082547824,0.978651933159394
451,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Up,0.564342082547824,0.978651933159394
452,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,7,Up,0.564528512026402,0.978651933159394
453,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,43,Up,0.566204961274066,0.978651933159394
454,WP_CALORIC_RESTRICTION_AND_AGING,7,Up,0.569888871805854,0.978651933159394
455,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,33,Down,0.570167857218102,0.978651933159394
456,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,24,Up,0.570947130513961,0.978651933159394
457,WP_EBOLA_VIRUS_INFECTION_IN_HOST,105,Up,0.571056256034135,0.978651933159394
458,WP_NEUROINFLAMMATION,10,Down,0.571292457889618,0.978651933159394
459,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,11,Up,0.572220018343005,0.978651933159394
460,WP_SULFATASE_AND_AROMATASE_PATHWAY,4,Up,0.573377773132629,0.978651933159394
461,WP_ALANINE_AND_ASPARTATE_METABOLISM,5,Down,0.574043428804461,0.978651933159394
462,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Up,0.574204909424937,0.978651933159394
463,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Down,0.574341255710517,0.978651933159394
464,WP_LEPTIN_AND_ADIPONECTIN,8,Down,0.575866776952785,0.978651933159394
465,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Up,0.576365856614204,0.978651933159394
466,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Up,0.581558885219489,0.978651933159394
467,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,32,Down,0.581608811696741,0.978651933159394
468,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,24,Up,0.583521126507711,0.978651933159394
469,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,11,Down,0.583858420958501,0.978651933159394
470,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Down,0.583991275939946,0.978651933159394
471,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,23,Down,0.585383736276309,0.978651933159394
472,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Up,0.585481708023253,0.978651933159394
473,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,21,Up,0.588700508510789,0.978651933159394
474,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,13,Up,0.588739890757695,0.978651933159394
475,WP_IL18_SIGNALING,189,Up,0.591159346074921,0.978651933159394
476,WP_TYPE_III_INTERFERON_SIGNALING,7,Down,0.591728437249023,0.978651933159394
477,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,12,Up,0.594848830508007,0.978651933159394
478,WP_DISORDERS_IN_KETOLYSIS,4,Down,0.594975327711688,0.978651933159394
479,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Down,0.595197558220075,0.978651933159394
480,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Down,0.597016171017072,0.978651933159394
481,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,52,Up,0.597149515065635,0.978651933159394
482,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Down,0.598565237342991,0.978651933159394
483,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,51,Down,0.599037359019016,0.978651933159394
484,WP_IL17_SIGNALING,25,Down,0.599793661520351,0.978651933159394
485,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Down,0.600147623177063,0.978651933159394
486,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,25,Up,0.601054837132604,0.978651933159394
487,WP_DOPAMINERGIC_NEUROGENESIS,4,Down,0.602445933739611,0.978651933159394
488,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,14,Down,0.605430948046227,0.978651933159394
489,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,13,Up,0.607271595406571,0.978651933159394
490,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,4,Down,0.608303085616672,0.978651933159394
491,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Down,0.610306951527499,0.978651933159394
492,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Up,0.611787056578095,0.978651933159394
493,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,17,Down,0.612531964858818,0.978651933159394
494,WP_RALA_DOWNSTREAM_REGULATED_GENES,12,Up,0.61387702608401,0.978651933159394
495,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,9,Down,0.614180884023085,0.978651933159394
496,WP_BENZENE_METABOLISM,3,Up,0.614721388333618,0.978651933159394
497,WP_RETT_SYNDROME,31,Down,0.616343494153758,0.978651933159394
498,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,30,Up,0.616414094842976,0.978651933159394
499,WP_BLADDER_CANCER,29,Up,0.617275757402547,0.978651933159394
500,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Up,0.617547189680645,0.978651933159394
501,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,45,Up,0.618433401026488,0.978651933159394
502,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,20,Down,0.619771354449433,0.978651933159394
503,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,74,Up,0.619827036250386,0.978651933159394
504,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Down,0.620051941301943,0.978651933159394
505,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Up,0.620078311134557,0.978651933159394
506,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Down,0.621826518795772,0.978651933159394
507,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,41,Up,0.622064036036759,0.978651933159394
508,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,9,Down,0.622820704183323,0.978651933159394
509,WP_VITAMIN_B12_DISORDERS,9,Down,0.622879776513379,0.978651933159394
510,WP_MTHFR_DEFICIENCY,18,Up,0.623400236702694,0.978651933159394
511,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,7,Up,0.626357307299506,0.978651933159394
512,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,13,Down,0.626384908202763,0.978651933159394
513,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,24,Down,0.627091329308942,0.978651933159394
514,WP_5Q35_COPY_NUMBER_VARIATION,76,Up,0.627109206116929,0.978651933159394
515,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Up,0.627116064257909,0.978651933159394
516,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,14,Down,0.628071900812879,0.978651933159394
517,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,102,Down,0.628535162395458,0.978651933159394
518,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Down,0.629055577909311,0.978651933159394
519,WP_NEPHROTIC_SYNDROME,27,Up,0.629962794976484,0.978651933159394
520,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,65,Down,0.631893898720348,0.978651933159394
521,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,12,Down,0.632207112528906,0.978651933159394
522,WP_NUCLEOTIDE_EXCISION_REPAIR,43,Up,0.634260535246805,0.978651933159394
523,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Up,0.634684905690602,0.978651933159394
524,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,37,Down,0.638729424036611,0.978651933159394
525,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,8,Down,0.639680459283446,0.978651933159394
526,WP_BENZOAPYRENE_METABOLISM,5,Up,0.641954111442539,0.978651933159394
527,WP_VALPROIC_ACID_PATHWAY,9,Down,0.643504570682533,0.978651933159394
528,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Down,0.644861604769386,0.978651933159394
529,WP_OVARIAN_INFERTILITY,21,Down,0.645503207679165,0.978651933159394
530,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,32,Up,0.646739462040744,0.978651933159394
531,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Down,0.648290575260106,0.978651933159394
532,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,22,Down,0.649956653535711,0.978651933159394
533,WP_IL26_SIGNALING,31,Down,0.652275490933066,0.978651933159394
534,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,10,Down,0.65233345769325,0.978651933159394
535,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Down,0.652356189552563,0.978651933159394
536,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,84,Up,0.653759023965978,0.978651933159394
537,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,19,Up,0.654512253273018,0.978651933159394
538,WP_CILIOPATHIES,127,Down,0.655736741067707,0.978651933159394
539,WP_AXON_GUIDANCE,38,Up,0.656009956989526,0.978651933159394
540,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,12,Down,0.656342178522234,0.978651933159394
541,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,17,Down,0.661721203371627,0.978651933159394
542,WP_ENDODERM_DIFFERENTIATION,84,Up,0.661873779170365,0.978651933159394
543,WP_COMPLEMENT_AND_COAGULATION_CASCADES,23,Up,0.66194590185913,0.978651933159394
544,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,23,Up,0.66194590185913,0.978651933159394
545,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,4,Down,0.662657783203285,0.978651933159394
546,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,72,Down,0.666046985291085,0.978651933159394
547,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,6,Down,0.66785535845063,0.978651933159394
548,WP_CHEMOKINE_SIGNALING,110,Down,0.670257042283519,0.978651933159394
549,WP_PDGF_PATHWAY,36,Down,0.672355796874589,0.978651933159394
550,WP_NEPHROGENESIS,4,Down,0.672375181827153,0.978651933159394
551,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Down,0.676425703151458,0.978651933159394
552,WP_TYPE_II_INTERFERON_SIGNALING,30,Down,0.677724729722641,0.978651933159394
553,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,64,Down,0.67892630162424,0.978651933159394
554,WP_PLEURAL_MESOTHELIOMA,254,Up,0.680327086482561,0.978651933159394
555,WP_GPR40_PATHWAY,8,Up,0.682193725459579,0.978651933159394
556,WP_GASTRIN_SIGNALING,92,Up,0.682416634956459,0.978651933159394
557,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Down,0.683098051455927,0.978651933159394
558,WP_UREA_CYCLE_AND_RELATED_DISEASES,3,Up,0.685386851330125,0.978651933159394
559,WP_FATTY_ACID_OMEGAOXIDATION,2,Up,0.685485666838206,0.978651933159394
560,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,3,Up,0.687258682631003,0.978651933159394
561,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,61,Up,0.68779870223408,0.978651933159394
562,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,20,Down,0.689463248220863,0.978651933159394
563,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,175,Up,0.690111501078367,0.978651933159394
564,WP_ACUTE_MYELOID_LEUKEMIA,55,Up,0.691425441442898,0.978651933159394
565,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,80,Up,0.692878110779545,0.978651933159394
566,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,69,Down,0.697422000008228,0.978651933159394
567,WP_TYPE_II_DIABETES_MELLITUS,14,Down,0.699334398634378,0.978651933159394
568,WP_INTEGRINMEDIATED_CELL_ADHESION,72,Down,0.700059470729106,0.978651933159394
569,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Up,0.700297591268189,0.978651933159394
570,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,46,Down,0.700540034471338,0.978651933159394
571,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Down,0.702216743586066,0.978651933159394
572,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,11,Down,0.703020401469452,0.978651933159394
573,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Up,0.703693494277946,0.978651933159394
574,WP_PI3KAKT_SIGNALING,178,Up,0.703721874494717,0.978651933159394
575,WP_HOMOLOGOUS_RECOMBINATION,11,Down,0.705077707443798,0.978651933159394
576,WP_ECTODERM_DIFFERENTIATION,78,Up,0.705329861692826,0.978651933159394
577,WP_KREBS_CYCLE_DISORDERS,11,Down,0.706050705568421,0.978651933159394
578,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Up,0.706456988163096,0.978651933159394
579,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,6,Down,0.706842449304007,0.978651933159394
580,WP_RETINOBLASTOMA_GENE_IN_CANCER,72,Up,0.707814303325404,0.978651933159394
581,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,7,Up,0.708022192119587,0.978651933159394
582,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,18,Down,0.709985914230285,0.978651933159394
583,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,13,Down,0.710406833430917,0.978651933159394
584,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Down,0.711663601115922,0.978651933159394
585,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Down,0.712609184437472,0.978651933159394
586,WP_ANDROGEN_RECEPTOR_SIGNALING,77,Up,0.713628341088347,0.978651933159394
587,WP_OSTEOCLAST_SIGNALING,9,Down,0.714285955592668,0.978651933159394
588,WP_G1_TO_S_CELL_CYCLE_CONTROL,52,Down,0.716448420498102,0.978651933159394
589,WP_MATRIX_METALLOPROTEINASES,8,Up,0.719121647686348,0.978651933159394
590,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,25,Down,0.719256393354661,0.978651933159394
591,WP_SULINDAC_METABOLIC_PATHWAY,2,Down,0.722592164269005,0.978651933159394
592,WP_HIPPO_SIGNALING_REGULATION,44,Down,0.722855499406887,0.978651933159394
593,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,22,Down,0.724144860613596,0.978651933159394
594,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Up,0.724471282589462,0.978651933159394
595,WP_KETOGENESIS_AND_KETOLYSIS,6,Down,0.72472989500983,0.978651933159394
596,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,35,Up,0.72521250467758,0.978651933159394
597,WP_FATTY_ACID_BETAOXIDATION,29,Down,0.725291019714202,0.978651933159394
598,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Up,0.727204529489432,0.978651933159394
599,WP_WNT_SIGNALING_AND_PLURIPOTENCY,60,Down,0.727561142262178,0.978651933159394
600,WP_GLIAL_CELL_DIFFERENTIATION,4,Up,0.727913742580843,0.978651933159394
601,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Up,0.728192903330595,0.978651933159394
602,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Up,0.728374434181808,0.978651933159394
603,WP_OSTEOBLAST_SIGNALING,3,Up,0.728427934911317,0.978651933159394
604,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,271,Down,0.729008906158712,0.978651933159394
605,WP_GLIOBLASTOMA_SIGNALING,68,Up,0.729220848327695,0.978651933159394
606,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,166,Up,0.729418203151381,0.978651933159394
607,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,16,Up,0.729871172814909,0.978651933159394
608,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Up,0.729930821377709,0.978651933159394
609,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,7,Down,0.730830225683864,0.978651933159394
610,WP_TARGET_OF_RAPAMYCIN_SIGNALING,33,Down,0.732902526473815,0.978651933159394
611,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,19,Up,0.732981154815594,0.978651933159394
612,WP_VEGFAVEGFR2_SIGNALING,340,Up,0.733376033153806,0.978651933159394
613,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,3,Up,0.733458805667152,0.978651933159394
614,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,22,Up,0.733916920328546,0.978651933159394
615,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,40,Down,0.734019055078574,0.978651933159394
616,WP_VITAMIN_D_METABOLISM,6,Up,0.734366887422491,0.978651933159394
617,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,19,Down,0.734584236933511,0.978651933159394
618,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,17,Up,0.740720766244823,0.983589490746433
619,WP_OMEGA9_FATTY_ACID_SYNTHESIS,11,Down,0.741607827752115,0.983589490746433
620,WP_ENDOTHELIN_PATHWAYS,12,Up,0.743346381985321,0.983589490746433
621,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,106,Down,0.744377562896321,0.983589490746433
622,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,64,Down,0.746055090618281,0.983589490746433
623,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Up,0.748295337785322,0.983589490746433
624,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,74,Up,0.749244543175074,0.983589490746433
625,WP_MRNA_PROCESSING,124,Down,0.750470450531655,0.983589490746433
626,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Down,0.754729494237931,0.983589490746433
627,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,17,Up,0.756953542649668,0.983589490746433
628,WP_RANKLRANK_SIGNALING,47,Down,0.757696730794494,0.983589490746433
629,WP_LUNG_PATHOLOGY_OF_COVID19,14,Up,0.758018705986439,0.983589490746433
630,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,23,Up,0.758055397164965,0.983589490746433
631,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Down,0.758231311020714,0.983589490746433
632,WP_LUNG_FIBROSIS,33,Down,0.760311911750969,0.983589490746433
633,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,57,Up,0.760675799393629,0.983589490746433
634,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,24,Up,0.761682679023693,0.983589490746433
635,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,19,Up,0.764009786085812,0.983589490746433
636,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,48,Up,0.767536835804285,0.983589490746433
637,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,20,Up,0.768574186456205,0.983589490746433
638,WP_NUCLEAR_RECEPTORS,20,Down,0.770348068071876,0.983589490746433
639,WP_NOTCH_SIGNALING_WP61,49,Up,0.770647511139085,0.983589490746433
640,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,8,Up,0.771631706437437,0.983589490746433
641,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Down,0.772750843006694,0.983589490746433
642,WP_IRINOTECAN_PATHWAY,5,Down,0.774358176946313,0.983589490746433
643,WP_METHYLATION_PATHWAYS,5,Up,0.776495446743094,0.983589490746433
644,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,11,Down,0.776833571696192,0.983589490746433
645,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,18,Up,0.780642364374705,0.983589490746433
646,WP_INSULIN_SIGNALING,130,Up,0.782052933210331,0.983589490746433
647,WP_IL2_SIGNALING,37,Down,0.782076247814835,0.983589490746433
648,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,47,Up,0.783621373504737,0.983589490746433
649,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,62,Up,0.784103616420087,0.983589490746433
650,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,34,Down,0.784780940138949,0.983589490746433
651,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,3,Down,0.786537737288277,0.983589490746433
652,WP_15Q11Q13_COPY_NUMBER_VARIATION,35,Down,0.787821033519065,0.983589490746433
653,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Up,0.793966925764313,0.983589490746433
654,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Up,0.795294427810229,0.983589490746433
655,WP_15Q25_COPY_NUMBER_VARIATION,28,Down,0.797351919612413,0.983589490746433
656,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,90,Down,0.798272465740691,0.983589490746433
657,WP_PURINE_METABOLISM,10,Down,0.799906370003605,0.983589490746433
658,WP_PDGFRBETA_PATHWAY,27,Down,0.800372955449779,0.983589490746433
659,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Up,0.800885163743986,0.983589490746433
660,WP_PROTEASOME_DEGRADATION,57,Down,0.801019085582923,0.983589490746433
661,WP_ALZHEIMERS_DISEASE,184,Down,0.801729769548795,0.983589490746433
662,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,184,Down,0.801729769548795,0.983589490746433
663,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,38,Down,0.802529733008799,0.983589490746433
664,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Up,0.805320908179325,0.983589490746433
665,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,3,Down,0.805372931923597,0.983589490746433
666,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,15,Down,0.805959850856458,0.983589490746433
667,WP_SPINA_BIFIDA,10,Down,0.806473238703286,0.983589490746433
668,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Up,0.80730301248095,0.983589490746433
669,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,18,Up,0.808220215734213,0.983589490746433
670,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Up,0.808545487505036,0.983589490746433
671,WP_CELL_CYCLE,95,Up,0.808919251683909,0.983589490746433
672,WP_SEROTONIN_TRANSPORTER_ACTIVITY,3,Down,0.810465766396879,0.983589490746433
673,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,36,Up,0.811005728553728,0.983589490746433
674,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,20,Up,0.818538561140085,0.983589490746433
675,WP_6Q16_COPY_NUMBER_VARIATION,5,Up,0.819315901645201,0.983589490746433
676,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Up,0.81945624767344,0.983589490746433
677,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,9,Up,0.821574512601888,0.983589490746433
678,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,9,Up,0.821574512601888,0.983589490746433
679,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,126,Up,0.821600461046348,0.983589490746433
680,WP_DNA_MISMATCH_REPAIR,21,Up,0.824621078978115,0.983589490746433
681,WP_TNFALPHA_SIGNALING,84,Down,0.825399169623935,0.983589490746433
682,WP_GPCRS_CLASS_A_RHODOPSINLIKE,43,Up,0.826546963629507,0.983589490746433
683,WP_CELLULAR_PROTEOSTASIS,6,Down,0.826800519766755,0.983589490746433
684,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,12,Up,0.8277061492343,0.983589490746433
685,WP_PYRIMIDINE_METABOLISM,71,Up,0.82957772301939,0.983589490746433
686,WP_GASTRIC_CANCER_NETWORK_2,26,Down,0.829934874190259,0.983589490746433
687,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,31,Down,0.832993898165094,0.983589490746433
688,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,21,Up,0.833075103429276,0.983589490746433
689,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Up,0.833509382402722,0.983589490746433
690,WP_INCLUSION_BODY_MYOSITIS,9,Up,0.83640795689514,0.983589490746433
691,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Up,0.837618837880713,0.983589490746433
692,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Up,0.837908365485933,0.983589490746433
693,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,45,Up,0.838753305383844,0.983589490746433
694,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,3,Up,0.839855708922612,0.983589490746433
695,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,32,Up,0.843924568614075,0.983589490746433
696,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,10,Up,0.845198597035735,0.983589490746433
697,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Up,0.845321565860889,0.983589490746433
698,WP_FLUOROPYRIMIDINE_ACTIVITY,25,Up,0.846125590670935,0.983589490746433
699,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Up,0.848825862379501,0.983589490746433
700,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,49,Down,0.850339186398292,0.983589490746433
701,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Down,0.852009573836932,0.983589490746433
702,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,38,Down,0.85542293589703,0.983589490746433
703,WP_SILDENAFIL_TREATMENT,11,Up,0.85682176421147,0.983589490746433
704,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Down,0.857095085355133,0.983589490746433
705,WP_TCELL_RECEPTOR_SIGNALING,72,Down,0.857818207544994,0.983589490746433
706,WP_LIPID_PARTICLES_COMPOSITION,5,Up,0.858842599688663,0.983589490746433
707,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Up,0.85913961605461,0.983589490746433
708,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,9,Up,0.85920659834803,0.983589490746433
709,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,10,Down,0.860294778240614,0.983589490746433
710,WP_IL19_SIGNALING,20,Down,0.862348964422691,0.983589490746433
711,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,21,Up,0.862635390352544,0.983589490746433
712,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,27,Down,0.863352036774726,0.983589490746433
713,WP_TGFBETA_RECEPTOR_SIGNALING,35,Down,0.864151864869605,0.983589490746433
714,WP_NONSMALL_CELL_LUNG_CANCER,60,Up,0.864906623730442,0.983589490746433
715,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,28,Up,0.865027051534715,0.983589490746433
716,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,43,Up,0.865238149409076,0.983589490746433
717,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,46,Down,0.865952624967093,0.983589490746433
718,WP_TCELL_ACTIVATION_SARSCOV2,60,Up,0.866110818513922,0.983589490746433
719,WP_ONCOSTATIN_M_SIGNALING,55,Down,0.866510541540772,0.983589490746433
720,WP_KIT_RECEPTOR_SIGNALING,51,Down,0.867190424667991,0.983589490746433
721,WP_WNT_SIGNALING_WP363,38,Up,0.869219387359958,0.983589490746433
722,WP_NONHOMOLOGOUS_END_JOINING,10,Up,0.872156287357664,0.983589490746433
723,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,15,Up,0.872401249680126,0.983589490746433
724,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,41,Down,0.873537397430557,0.983589490746433
725,WP_KALLMANN_SYNDROME,11,Up,0.874240438586236,0.983589490746433
726,WP_DNA_REPLICATION,36,Down,0.874746021615127,0.983589490746433
727,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,2,Up,0.876393301278633,0.983589490746433
728,WP_NRF2ARE_REGULATION,20,Up,0.876751912434689,0.983589490746433
729,WP_MACROPHAGE_MARKERS,8,Up,0.877326961956817,0.983589490746433
730,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,15,Down,0.878638254679303,0.983589490746433
731,WP_PROLACTIN_SIGNALING,69,Up,0.878907713984099,0.983589490746433
732,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,13,Down,0.87929173969081,0.983589490746433
733,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,15,Up,0.881674701266485,0.983589490746433
734,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Up,0.885070015982847,0.983589490746433
735,WP_IL9_SIGNALING,15,Down,0.885594662203164,0.983589490746433
736,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,9,Up,0.885735126986953,0.983589490746433
737,WP_ESTROGEN_METABOLISM_WP5276,9,Down,0.886296160671719,0.983589490746433
738,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,26,Up,0.886883360071152,0.983589490746433
739,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,14,Down,0.887464347230053,0.983589490746433
740,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,37,Down,0.890768572285203,0.983589490746433
741,WP_INTERFERONMEDIATED_SIGNALING,15,Down,0.891124037491082,0.983589490746433
742,WP_KLEEFSTRA_SYNDROME,25,Up,0.895459749847281,0.983589490746433
743,WP_NGLYCAN_BIOSYNTHESIS,52,Down,0.896940399946058,0.983589490746433
744,WP_IL6_SIGNALING,38,Down,0.897362599396607,0.983589490746433
745,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,23,Up,0.898006466995749,0.983589490746433
746,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Up,0.89805275571905,0.983589490746433
747,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,24,Down,0.899062727659019,0.983589490746433
748,WP_HISTONE_MODIFICATIONS,37,Up,0.903229498491711,0.983589490746433
749,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Down,0.903862383944874,0.983589490746433
750,WP_METASTATIC_BRAIN_TUMOR,6,Up,0.904528136757499,0.983589490746433
751,WP_IL11_SIGNALING,40,Down,0.904719794266302,0.983589490746433
752,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Down,0.905423158843713,0.983589490746433
753,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,17,Up,0.905428393086809,0.983589490746433
754,WP_TOLLLIKE_RECEPTOR_SIGNALING,79,Up,0.906372067027543,0.983589490746433
755,WP_ADIPOGENESIS,86,Up,0.90743586533507,0.983589490746433
756,WP_CANONICAL_NFKB_PATHWAY,8,Up,0.909092616058228,0.983589490746433
757,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,57,Up,0.909374145735506,0.983589490746433
758,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,40,Up,0.91325413679101,0.983589490746433
759,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Down,0.913778640759228,0.983589490746433
760,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Up,0.915430492359337,0.983589490746433
761,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Up,0.916257903608164,0.983589490746433
762,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,12,Down,0.916978063322645,0.983589490746433
763,WP_PHOSPHOINOSITIDES_METABOLISM,38,Up,0.918544070685166,0.983589490746433
764,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Down,0.91949228180077,0.983589490746433
765,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Down,0.919632128171968,0.983589490746433
766,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,16,Up,0.919900674783774,0.983589490746433
767,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Down,0.920897145198008,0.983589490746433
768,WP_AMINO_ACID_METABOLISM,59,Up,0.921765209083207,0.983589490746433
769,WP_MIRNA_BIOGENESIS,6,Down,0.922699695111353,0.983589490746433
770,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,18,Down,0.923061797036242,0.983589490746433
771,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,4,Down,0.924479463532901,0.983589490746433
772,WP_CILIARY_LANDSCAPE,185,Up,0.924568329382637,0.983589490746433
773,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Down,0.925202090053588,0.983589490746433
774,WP_GLUTATHIONE_METABOLISM,10,Up,0.926820707923368,0.983589490746433
775,WP_DRAVET_SYNDROME,14,Down,0.927754184781448,0.983589490746433
776,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,37,Up,0.92854676985308,0.983589490746433
777,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,16,Down,0.930315110361661,0.98419436385751
778,WP_B_CELL_RECEPTOR_SIGNALING,85,Down,0.933297371391344,0.986080256148695
779,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,21,Up,0.936405590097326,0.987486801503482
780,WP_FOCAL_ADHESION,119,Up,0.939204340949111,0.987486801503482
781,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,7,Up,0.940728026426756,0.987486801503482
782,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Down,0.941132898039763,0.987486801503482
783,WP_ATM_SIGNALING,34,Up,0.941718737919146,0.987486801503482
784,WP_JOUBERT_SYNDROME,71,Up,0.943212800428511,0.987486801503482
785,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,23,Down,0.943350634865197,0.987486801503482
786,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,3,Up,0.94443110923394,0.987486801503482
787,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,18,Down,0.945440526500293,0.987486801503482
788,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,41,Up,0.948660465647368,0.989592516195604
789,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,38,Down,0.951005782671468,0.98983589081038
790,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,82,Down,0.954243702751297,0.98983589081038
791,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,8,Down,0.955238769715908,0.98983589081038
792,WP_AUTOPHAGY,27,Down,0.955812458330194,0.98983589081038
793,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Down,0.96040790035626,0.98983589081038
794,WP_CYTOSINE_METHYLATION,7,Up,0.961216755787545,0.98983589081038
795,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,11,Down,0.961263247829314,0.98983589081038
796,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,36,Down,0.961825596633396,0.98983589081038
797,WP_RAC1PAK1P38MMP2_PATHWAY,51,Up,0.961906513548472,0.98983589081038
798,WP_WHITE_FAT_CELL_DIFFERENTIATION,23,Down,0.963286511397969,0.98983589081038
799,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,20,Up,0.96413888695846,0.98983589081038
800,WP_REGULATION_OF_ACTIN_CYTOSKELETON,93,Up,0.966635477292373,0.98983589081038
801,WP_BDNFTRKB_SIGNALING,26,Down,0.966675434896235,0.98983589081038
802,WP_BARDETBIEDL_SYNDROME,65,Down,0.966797215276996,0.98983589081038
803,WP_HEPATITIS_B_INFECTION,116,Down,0.966956472409654,0.98983589081038
804,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,7,Down,0.968967084357663,0.990177690656424
805,WP_ACUTE_VIRAL_MYOCARDITIS,65,Down,0.970088654109034,0.990177690656424
806,WP_UROTENSINIIMEDIATED_SIGNALING,48,Up,0.970904158964815,0.990177690656424
807,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,56,Down,0.979749562718704,0.99699451078181
808,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,51,Up,0.980014068992339,0.99699451078181
809,WP_ACE_INHIBITOR_PATHWAY,5,Down,0.9816060383916,0.997379683013467
810,WP_UNFOLDED_PROTEIN_RESPONSE,24,Up,0.984337890802236,0.998723430080824
811,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Up,0.985358517999451,0.998723430080824
812,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,8,Up,0.991471965047612,0.99948628217218
813,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,14,Down,0.991800611097122,0.99948628217218
814,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,23,Up,0.992528972864407,0.99948628217218
815,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,25,Down,0.992850458633146,0.99948628217218
816,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,12,Up,0.994535423379942,0.99948628217218
817,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Down,0.995613302352503,0.99948628217218
818,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,12,Up,0.996874879284172,0.99948628217218
819,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Up,0.997135904077441,0.99948628217218
820,WP_7OXOC_AND_7BETAHC_PATHWAYS,18,Up,0.997856991240692,0.99948628217218
821,WP_ASPIRIN_AND_MIRNAS,8,Down,0.998270362120876,0.99948628217218
822,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Up,0.999862108347088,0.999862108347088
